Treating Patients with Cystic Fibrosis: Best Practices, Strategies, Updates 2021 (AMW) Session
2021 AAO-HNSF Annual Meeting & OTO Experience
Sixty percent of pediatric and adult patients with Cystic Fibrosis (CF) report chronic rhinosinusitis (CRS) symptoms when questioned and endoscopic and radiographic evidence of sinonasal inflammation is nearly universal. Frontal headaches, anosmia, obstruction, discharge, and congestion are all common to the CF population. This panel of pediatric and adult rhinology experts will discuss the evaluation, medical management, imaging indications, surgical options, and long-term care of the pediatric and adult cystic fibrosis patient. The introduction of new Cystic Fibrosis Transmembrane Receptor corrector/modulator medical therapy will also be reviewed, and cases discussed.
Description
Learning Objective: 1. Evaluate and treat the cystic fibrosis patient. Understand how Cystic Fibrosis Transmembrane Receptor corrector/modulators work. 2. Determine how to incorporate surgical intervention into cystic fibrosis care. Follow best practice for imaging. 3. Learn culture directed techniques to manage long term sinus colonization/biofilm formation. Establish a guideline for in-office debridement of cystic fibrosis patients. Faculty: Amanda Stapleton, MD(Nothing to Disclose), Brent Senior, MD(Nothing to Disclose), Stella Lee, MD(Consulting Fee: AstraZeneca, GlaxoSmithKline, Sanofi Regeneron), Adam Kimple (Nothing to Disclose).